Detalhe da pesquisa
1.
OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma.
Cancer
; 128(19): 3516-3522, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35942596
2.
Analysis of survival data with nonproportional hazards: A comparison of propensity-score-weighted methods.
Biom J
; : e202200099, 2022 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36541715
3.
Sorafenib for Advanced and Refractory Desmoid Tumors.
N Engl J Med
; 379(25): 2417-2428, 2018 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30575484
4.
A Phase I Study of Binimetinib (MEK162) Combined with Pexidartinib (PLX3397) in Patients with Advanced Gastrointestinal Stromal Tumor.
Oncologist
; 24(10): 1309-e983, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31213500
5.
Retroperitoneal Sarcomas: Does Laterality Matter?
J Surg Res
; 244: 34-41, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31279261
6.
Role of Molecular Profiling in Soft Tissue Sarcoma.
J Natl Compr Canc Netw
; 16(5): 564-571, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29752329
7.
Granular cell tumor experience at a comprehensive cancer center.
J Surg Res
; 226: 1-7, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29661274
8.
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.
Lancet Oncol
; 18(11): 1493-1501, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28988646
9.
NCCN Guidelines Insights: Bone Cancer, Version 2.2017.
J Natl Compr Canc Netw
; 15(2): 155-167, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28188186
10.
FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors.
J Transl Med
; 14(1): 339, 2016 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27974047
11.
Patterns of Chemotherapy Administration in High-Risk Soft Tissue Sarcoma and Impact on Overall Survival.
J Natl Compr Canc Netw
; 13(11): 1366-74, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26553766
12.
Role of genetic and molecular profiling in sarcomas.
Curr Treat Options Oncol
; 16(5): 24, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25939540
13.
Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma.
Clin Cancer Res
; 30(10): 2260-2271, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38488807
14.
SAR-096: Phase II Clinical Trial of Ribociclib in Combination with Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS).
Clin Cancer Res
; 30(2): 315-322, 2024 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37967116
15.
Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma.
Clin Cancer Res
; 30(4): 703-718, 2024 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37695642
16.
Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma.
Clin Cancer Res
; 29(7): 1200-1208, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36302173
17.
Immune-related Adverse Events after Immune Checkpoint Blockade-based Therapy Are Associated with Improved Survival in Advanced Sarcomas.
Cancer Res Commun
; 3(10): 2118-2125, 2023 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37787759
18.
A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma.
Clin Cancer Res
; 29(11): 2043-2051, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36971773
19.
Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced Sarcoma.
Clin Cancer Res
; 28(5): 939-947, 2022 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34965948
20.
Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center.
J Immunother Cancer
; 10(4)2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35365586